Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis

Abstract

Among patients with myelodysplastic syndromes, only severe fibrosis affects survival after hematopoietic stem cell transplantation while patients with mild or moderate fibrosis have an outcome comparable to that of patients without bone marrow fibrosis.